This analysis included 1778 female participants of the Diabetes Prevention Program Outcomes Study who had been randomly assigned during the Diabetes Prevention Program to intensive lifestyle intervention ( n = 582 ) , metformin ( n = 589 ) or placebo ( n = 607 ) .